{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:07Z","timestamp":1791223627629,"version":"4.1.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03348-z","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:17:11Z","timestamp":1769818631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9658-6152","authenticated-orcid":false,"given":"Kailash","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7702-477X","authenticated-orcid":false,"given":"Amit","family":"Mukharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-869X","authenticated-orcid":false,"given":"Anil B.","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"3348_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jconrel.2022.12.029","volume":"353","author":"LE McCoubrey","year":"2023","unstructured":"McCoubrey LE, Favaron A, Awad A, Orlu M, Gaisford S, Basit AW. Colonic drug delivery: formulating the next generation of colon-targeted therapeutics. J Control Release. 2023;353:1107\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.029.","journal-title":"J Control Release"},{"key":"3348_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4137\/CGast.S12731","volume":"6","author":"AE M'Koma","year":"2013","unstructured":"M\u2019Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33\u201347. https:\/\/doi.org\/10.4137\/CGast.S12731.","journal-title":"Clin Med Insights Gastroenterol"},{"issue":"3","key":"3348_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030871","volume":"15","author":"V Laredo","year":"2023","unstructured":"Laredo V, Garc\u00eda-Mateo S, Mart\u00ednez-Dom\u00ednguez SJ, de la L\u00f3pez Cruz J, Gargallo-Puyuelo CJ, Gomoll\u00f3n F. Risk of cancer in patients with inflammatory bowel diseases and keys for patient management. Cancers. 2023;15(3):871. https:\/\/doi.org\/10.3390\/cancers15030871.","journal-title":"Cancers"},{"key":"3348_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113828","volume":"175","author":"O Hartwig","year":"2021","unstructured":"Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa \u2013 targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev. 2021;175:113828. https:\/\/doi.org\/10.1016\/j.addr.2021.113828.","journal-title":"Adv Drug Deliv Rev"},{"key":"3348_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121364","volume":"281","author":"NG Kotla","year":"2022","unstructured":"Kotla NG, Singh R, Baby BV, Rasala S, Rasool J, Hynes SO, et al. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease. Biomaterials. 2022;281:121364. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121364.","journal-title":"Biomaterials"},{"key":"3348_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2023.100721","volume":"99","author":"GM Ahlawat","year":"2023","unstructured":"Ahlawat GM, Singh PK. Methods of determining irritable bowel syndrome and efficiency of probiotics in treatment: a review. Curr Ther Res. 2023;99:100721. https:\/\/doi.org\/10.1016\/j.curtheres.2023.100721.","journal-title":"Curr Ther Res"},{"key":"3348_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2024.107205","volume":"101","author":"A Kumar","year":"2025","unstructured":"Kumar A, Aravind N, Gillani T, Kumar D. Artificial intelligence breakthrough in diagnosis, treatment, and prevention of colorectal cancer \u2013 a comprehensive review. Biomed Signal Process Control. 2025;101:107205. https:\/\/doi.org\/10.1016\/j.bspc.2024.107205.","journal-title":"Biomed Signal Process Control"},{"issue":"1","key":"3348_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2019.151358","volume":"310","author":"JC Carrero","year":"2020","unstructured":"Carrero JC, Reyes-L\u00f3pez M, Serrano-Luna J, Shibayama M, Unzueta J, Le\u00f3n-Sicairos N, et al. Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. Int J Med Microbiol. 2020;310(1):151358. https:\/\/doi.org\/10.1016\/j.ijmm.2019.151358.","journal-title":"Int J Med Microbiol"},{"issue":"7","key":"3348_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.gastre.2020.12.003","volume":"44","author":"D Saavedra-Perez","year":"2021","unstructured":"Saavedra-Perez D, Curbelo-Pe\u00f1a Y, Sampson-Davila J, Albertos S, Serrano A, Iba\u00f1ez L, et al. Management of symptomatic uncomplicated diverticular colon disease: a systematic review of diagnosis and treatment. Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition). 2021;44(7):497\u2013518. https:\/\/doi.org\/10.1016\/j.gastre.2020.12.003.","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition)"},{"issue":"4","key":"3348_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9040041","volume":"9","author":"L Lin","year":"2017","unstructured":"Lin L, Wong H. Predicting oral drug absorption: mini review on physiologically-based pharmacokinetic models. Pharmaceutics. 2017;9(4):41. https:\/\/doi.org\/10.3390\/pharmaceutics9040041.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3348_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/japtr.JAPTR_26_19","volume":"10","author":"N Belali","year":"2019","unstructured":"Belali N, Wathoni N, Muchtaridi M. Advances in orally targeted drug delivery to colon. J Adv Pharm Technol Res. 2019;10(3):100\u20136. https:\/\/doi.org\/10.4103\/japtr.JAPTR_26_19.","journal-title":"J Adv Pharm Technol Res"},{"issue":"1","key":"3348_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12010068","volume":"12","author":"SH Lee","year":"2020","unstructured":"Lee SH, Bajracharya R, Min JY, Han J-W, Park BJ, Han H-K. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics. 2020;12(1):68. https:\/\/doi.org\/10.3390\/pharmaceutics12010068.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3348_CR13","first-page":"163","volume":"2","author":"VV Prasanth","year":"2012","unstructured":"Prasanth VV, Jayaprakash R, Mathew ST. Colon specific drug delivery systems: a review on various pharmaceutical approaches. J Appl Pharm Sci. 2012;2(1):163\u20139.","journal-title":"J Appl Pharm Sci"},{"issue":"11","key":"3348_CR14","doi-asserted-by":"publisher","first-page":"26936","DOI":"10.3390\/ijms161125995","volume":"16","author":"C Lin","year":"2015","unstructured":"Lin C, Ng HLH, Pan W, Chen H, Zhang G, Bian Z, et al. Exploring different strategies for efficient delivery of colorectal cancer therapy. Int J Mol Sci. 2015;16(11):26936\u201352. https:\/\/doi.org\/10.3390\/ijms161125995.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3348_CR15","first-page":"5763","volume":"10","author":"M Patel","year":"2021","unstructured":"Patel M, Nagarkar R, Mohammed IA, Shah S, Kulal S. Colon targeted drug delivery system: recent approaches. Int J Bioassays. 2021;10(1):5763\u201377.","journal-title":"Int J Bioassays"},{"key":"3348_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.139177","volume":"302","author":"H Shao","year":"2025","unstructured":"Shao H, Liu M, Jiang H, Zhang Y. Polysaccharide-based drug delivery targeted approach for colon cancer treatment: a comprehensive review. Int J Biol Macromol. 2025;302:139177. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139177.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3348_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2024.100943","volume":"19","author":"B Zheng","year":"2024","unstructured":"Zheng B, Wang L, Yi Y, Yin J, Liang A. Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease. Asian J Pharm Sci. 2024;19(4):100943. https:\/\/doi.org\/10.1016\/j.ajps.2024.100943.","journal-title":"Asian J Pharm Sci"},{"issue":"1\u20132","key":"3348_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijpharm.2006.05.015","volume":"321","author":"O Chambin","year":"2006","unstructured":"Chambin O, Dupuis G, Champion D, Voilley A, Pourcelot Y. Colon-specific drug delivery: influence of solution reticulation properties upon pectin beads performance. Int J Pharm. 2006;321(1\u20132):86\u201393. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.05.015.","journal-title":"Int J Pharm"},{"key":"3348_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110486","volume":"129","author":"X Li","year":"2020","unstructured":"Li X, Lu C, Yang Y, Yu C, Rao Y. Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease. Biomed Pharmacother. 2020;129:110486. https:\/\/doi.org\/10.1016\/j.biopha.2020.110486.","journal-title":"Biomed Pharmacother"},{"key":"3348_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5001\/omj.2010.24","volume":"25","author":"AK Philip","year":"2010","unstructured":"Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2010;25:70\u20138. https:\/\/doi.org\/10.5001\/omj.2010.24.","journal-title":"Oman Med J"},{"key":"3348_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105472","volume":"93","author":"SH Sardou","year":"2024","unstructured":"Sardou SH, Abbaspour M, Akhgari A, Kesharwani P, Sahebkar A. Colon-targeted delivery systems of budesonide as second-line therapy in inflammatory bowel disease. J Drug Deliv Sci Technol. 2024;93:105472. https:\/\/doi.org\/10.1016\/j.jddst.2024.105472.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2019.02.030","volume":"561","author":"D Ferri","year":"2019","unstructured":"Ferri D, Costero AM, Gavi\u00f1a P, Parra M, Merino V, Teruel AH, et al. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis. Int J Pharm. 2019;561:93\u2013101. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.030.","journal-title":"Int J Pharm"},{"key":"3348_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00524","volume":"11","author":"S Hua","year":"2020","unstructured":"Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract \u2013 influence of physiological, pathophysiological and pharmaceutical factors. Front Pharmacol. 2020;11:524. https:\/\/doi.org\/10.3389\/fphar.2020.00524.","journal-title":"Front Pharmacol"},{"key":"3348_CR24","unstructured":"Evonik. EUDRAGIT\u00ae functional polymers for oral solid dosage forms. 2025. https:\/\/healthcare.evonik.com\/en\/drugdelivery\/oral-drug-delivery\/oral-excipients\/eudragit-portfolio. Accessed 17 May 2025."},{"key":"3348_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","volume":"558","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered ph-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm. 2019;558:201\u201314. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.12.074.","journal-title":"Int J Pharm"},{"issue":"2","key":"3348_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020226","volume":"17","author":"Y Gvozdeva","year":"2025","unstructured":"Gvozdeva Y, Staynova R. pH-dependent drug delivery systems for ulcerative colitis treatment. Pharmaceutics. 2025;17(2):226. https:\/\/doi.org\/10.3390\/pharmaceutics17020226.","journal-title":"Pharmaceutics"},{"key":"3348_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2018.10.009","volume":"136","author":"A Bak","year":"2018","unstructured":"Bak A, Ashford M, Brayden DJ. Local delivery of macromolecules to treat diseases associated with the colon. Adv Drug Deliv Rev. 2018;136:2\u201327. https:\/\/doi.org\/10.1016\/j.addr.2018.10.009.","journal-title":"Adv Drug Deliv Rev"},{"key":"3348_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejps.2019.04.013","volume":"134","author":"M Vertzoni","year":"2019","unstructured":"Vertzoni M, Augustijns P, Grimm M, Koziolek M, Lemmens G, Parrott N, et al. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. Eur J Pharm Sci. 2019;134:153\u201375. https:\/\/doi.org\/10.1016\/j.ejps.2019.04.013.","journal-title":"Eur J Pharm Sci"},{"key":"3348_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118530","volume":"272","author":"M Cui","year":"2021","unstructured":"Cui M, Zhang M, Liu K. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: a review. Carbohydr Polym. 2021;272:118530. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118530.","journal-title":"Carbohydr Polym"},{"key":"3348_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41575-025-01092-6","volume":"22","author":"JE Brinck","year":"2025","unstructured":"Brinck JE, Sinha AK, Laursen MF, et al. Intestinal pH: a major driver of human gut microbiota composition and metabolism. Nat Rev Gastroenterol Hepatol. 2025;22:639\u201356. https:\/\/doi.org\/10.1038\/s41575-025-01092-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3348_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejpb.2016.02.002","volume":"101","author":"M Kataoka","year":"2016","unstructured":"Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, et al. Effects of gastric pH on oral drug absorption: in vitro assessment using a dissolution\/permeation system reflecting the gastric dissolution process. Eur J Pharm Biopharm. 2016;101:103\u201311. https:\/\/doi.org\/10.1016\/j.ejpb.2016.02.002.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"3348_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1021\/mp100149j","volume":"7","author":"DM Mudie","year":"2010","unstructured":"Mudie DM, Amidon GL, Amidon GE. Physiological parameters for oral delivery and in vitro testing. Mol Pharm. 2010;7(5):1388\u2013405. https:\/\/doi.org\/10.1021\/mp100149j.","journal-title":"Mol Pharm"},{"key":"3348_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114906","volume":"199","author":"G Pastorin","year":"2023","unstructured":"Pastorin G, Benetti C, Wacker MG. From in vitro to in vivo: a comprehensive guide to IVIVC development for long-acting therapeutics. Adv Drug Deliv Rev. 2023;199:114906. https:\/\/doi.org\/10.1016\/j.addr.2023.114906.","journal-title":"Adv Drug Deliv Rev"},{"key":"3348_CR34","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-0417-8","volume":"22","author":"DM Mudie","year":"2020","unstructured":"Mudie DM, Samiei N, Marshall DJ, Amidon GE, Bergstr\u00f6m CAS. Selection of in vivo predictive dissolution media using drug substance and physiological properties. AAPS J. 2020;22:34. https:\/\/doi.org\/10.1208\/s12248-020-0417-8.","journal-title":"AAPS J"},{"key":"3348_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejpb.2023.10.011","volume":"193","author":"L Freerks","year":"2023","unstructured":"Freerks L, Arien T, Mackie C, Inghelbrecht S, Klein S. A toolbox for mimicking gastrointestinal conditions in children: design and evaluation of biorelevant dissolution media for mimicking paediatric gastric- and small intestinal conditions. Eur J Pharm Biopharm. 2023;193:144\u201357. https:\/\/doi.org\/10.1016\/j.ejpb.2023.10.011.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jddst.2017.09.010","volume":"43","author":"E Moghimipour","year":"2018","unstructured":"Moghimipour E, Dorkoosh FA, Rezaei M, Kouchak M, Fatahiasl J, Angali KA, et al. In vivo evaluation of pH and time-dependent polymers as coating agent for colonic delivery using central composite design. J Drug Deliv Sci Technol. 2018;43:50\u20136. https:\/\/doi.org\/10.1016\/j.jddst.2017.09.010.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"3348_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2015.03.039","volume":"486","author":"JK Czarnocka","year":"2015","unstructured":"Czarnocka JK, Alhnan MA. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products. Int J Pharm. 2015;486(1\u20132):167\u201374. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.03.039.","journal-title":"Int J Pharm"},{"issue":"11","key":"3348_CR38","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1517\/17425247.2013.821978","volume":"10","author":"T Yoshida","year":"2013","unstructured":"Yoshida T, Lai TC, Kwon GS, Sako K. pH- and ion-sensitive polymers for drug delivery. Expert Opin Drug Deliv. 2013;10(11):1497\u2013513. https:\/\/doi.org\/10.1517\/17425247.2013.821978.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1\u20132","key":"3348_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpharm.2016.03.027","volume":"505","author":"JM Maurer","year":"2016","unstructured":"Maurer JM, Hofman S, Schellekens RCA, Tonnis WF, Dubois AOT, Woerdenbag HJ, et al. Development and potential application of an oral ColoPulse infliximab tablet with colon specific release: a feasibility study. Int J Pharm. 2016;505(1\u20132):175\u201386. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.027.","journal-title":"Int J Pharm"},{"issue":"11","key":"3348_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112505","volume":"14","author":"FS Moghrabi","year":"2022","unstructured":"Moghrabi FS, Fadda HM. Drug physicochemical properties and capsule fill determine extent of premature gastric release from enteric capsules. Pharmaceutics. 2022;14(11):2505. https:\/\/doi.org\/10.3390\/pharmaceutics14112505.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3348_CR41","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/jps.23828","volume":"103","author":"D Gugulothu","year":"2014","unstructured":"Gugulothu D, Kulkarni A, Patravale V, Dandekar P. pH-sensitive nanoparticles of curcumin\u2013celecoxib combination: evaluating drug synergy in ulcerative colitis model. J Pharm Sci. 2014;103(2):687\u201396. https:\/\/doi.org\/10.1002\/jps.23828.","journal-title":"J Pharm Sci"},{"key":"3348_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122741","volume":"635","author":"Y Lv","year":"2023","unstructured":"Lv Y, Ren M, Yao M, Zou J, Fang S, Wang Y, et al. Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice. Int J Pharm. 2023;635:122741. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122741.","journal-title":"Int J Pharm"},{"key":"3348_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000165","volume":"4","author":"Z Qu","year":"2021","unstructured":"Qu Z, Wong KY, Moniruzzaman M, Begun J, Santos HA, Hasnain SZ, et al. One-pot synthesis of pH-responsive Eudragit\u2013mesoporous silica nanocomposites enable colonic delivery of glucocorticoids for the treatment of inflammatory bowel disease. Adv Ther. 2021;4:2000165. https:\/\/doi.org\/10.1002\/adtp.202000165.","journal-title":"Adv Ther"},{"issue":"11","key":"3348_CR44","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1002\/jps.21742","volume":"98","author":"A Vaidya","year":"2009","unstructured":"Vaidya A, Jain A, Khare P, Agrawal RK, Jain SK. Metronidazole loaded pectin microspheres for colon targeting. J Pharm Sci. 2009;98(11):4229\u201336. https:\/\/doi.org\/10.1002\/jps.21742.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3348_CR45","first-page":"360","volume":"9","author":"KT Devi","year":"2019","unstructured":"Devi KT, Venkateswarlu BS. Formulation and characterization of satranidazole loaded polymeric nanoparticles. Int J Pharm Biol Sci. 2019;9(2):360\u201370.","journal-title":"Int J Pharm Biol Sci"},{"key":"3348_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejps.2016.09.035","volume":"96","author":"S Dhat","year":"2017","unstructured":"Dhat S, Pund S, Kokare C, Sharma P, Shrivastava B. Risk management and statistical multivariate analysis approach for design and optimization of satranidazole nanoparticles. Eur J Pharm Sci. 2017;96:273\u201383. https:\/\/doi.org\/10.1016\/j.ejps.2016.09.035.","journal-title":"Eur J Pharm Sci"},{"key":"3348_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijpharm.2019.01.066","volume":"559","author":"MNU Nguyen","year":"2019","unstructured":"Nguyen MNU, Tran PHL, Tran TTD. A single-layer film coating for colon-targeted oral delivery. Int J Pharm. 2019;559:402\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.066.","journal-title":"Int J Pharm"},{"issue":"7","key":"3348_CR48","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.gastre.2018.07.006","volume":"41","author":"A L\u00f3pez-Sanrom\u00e1n","year":"2018","unstructured":"L\u00f3pez-Sanrom\u00e1n A, Clofent J, Garcia-Planella E, Mench\u00e9n L, Nos P, Rodr\u00edguez-Lago I, et al. Reviewing the therapeutic role of budesonide in Crohn\u2019s disease. Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition). 2018;41(7):458\u201371. https:\/\/doi.org\/10.1016\/j.gastre.2018.07.006.","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition)"},{"key":"3348_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114076","volume":"181","author":"A Awad","year":"2022","unstructured":"Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, et al. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev. 2022;181:114076. https:\/\/doi.org\/10.1016\/j.addr.2021.114076.","journal-title":"Adv Drug Deliv Rev"},{"key":"3348_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121701","volume":"619","author":"A Van Camp","year":"2022","unstructured":"Van Camp A, Vanuytsel T, Brouwers J, Augustijns P. The effect of esomeprazole on the upper GI tract release and systemic absorption of mesalazine from colon targeted formulations. Int J Pharm. 2022;619:121701. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121701.","journal-title":"Int J Pharm"},{"key":"3348_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120347","volume":"597","author":"HS Sardou","year":"2021","unstructured":"Sardou HS, Akhgari A, Mohammadpour AH, Kamali H, Jafarian AH, Garekani HA, et al. Application of inulin\/Eudragit RS in 5-ASA pellet coating with tuned, sustained-release feature in an animal model of ulcerative colitis. Int J Pharm. 2021;597:120347. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120347.","journal-title":"Int J Pharm"},{"key":"3348_CR52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijpharm.2018.11.019","volume":"554","author":"B Gareb","year":"2019","unstructured":"Gareb B, Dijkstra G, Kosterink JGW, Frijlink HW. Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice. Int J Pharm. 2019;554:366\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.11.019.","journal-title":"Int J Pharm"},{"key":"3348_CR53","doi-asserted-by":"publisher","unstructured":"Kurakula M, Naveen NR, Yadav KS. Formulations for polymer coatings. In: Inamuddin, Boddula R, Ahamed MI, Asiri AM, editors. Polymer Coatings. Hoboken (NJ): Wiley; 2020.https:\/\/doi.org\/10.1002\/9781119655145.ch19.","DOI":"10.1002\/9781119655145.ch19"},{"key":"3348_CR54","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","volume":"47","author":"GH Son","year":"2017","unstructured":"Son GH, Lee BJ, Cho CW. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J Pharm Investig. 2017;47:287\u201396. https:\/\/doi.org\/10.1007\/s40005-017-0320-1.","journal-title":"J Pharm Investig"},{"issue":"3","key":"3348_CR55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jconrel.2004.03.034","volume":"97","author":"S Abdul","year":"2004","unstructured":"Abdul S, Poddar SS. A flexible technology for modified release of drugs: multi layered tablets. J Control Release. 2004;97(3):393\u2013405. https:\/\/doi.org\/10.1016\/j.jconrel.2004.03.034.","journal-title":"J Control Release"},{"key":"3348_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100015","volume":"2","author":"B Gowthami","year":"2021","unstructured":"Gowthami B, Gopala Krishna SV, Subba Rao D. Application of coating technology to chronotherapeutic drug delivery systems: recent publications and patents. Curr Res Pharmacol Drug Discov. 2021;2:100015. https:\/\/doi.org\/10.1016\/j.crphar.2021.100015.","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"9\u201310","key":"3348_CR57","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.addr.2010.04.010","volume":"62","author":"BC Youan","year":"2010","unstructured":"Youan BC. Chronopharmaceutical drug delivery systems: hurdles, hype or hope? Adv Drug Deliv Rev. 2010;62(9\u201310):898\u2013903. https:\/\/doi.org\/10.1016\/j.addr.2010.04.010.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3348_CR58","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jconrel.2012.09.012","volume":"163","author":"N Nainwal","year":"2012","unstructured":"Nainwal N. Chronotherapeutics \u2014 a chronopharmaceutical approach to drug delivery in the treatment of asthma. J Control Release. 2012;163(3):353\u201360. https:\/\/doi.org\/10.1016\/j.jconrel.2012.09.012.","journal-title":"J Control Release"},{"issue":"10","key":"3348_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29064","volume":"10","author":"A Rajput","year":"2024","unstructured":"Rajput A, Pingale P, Telange D, Musale S, Chalikwar S. A current era in pulsatile drug delivery system: drug journey based on chronobiology. Heliyon. 2024;10(10):e29064. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29064.","journal-title":"Heliyon"},{"key":"3348_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2019.04.011","volume":"303","author":"RSCMQ Antonino","year":"2019","unstructured":"Antonino RSCMQ, Nascimento TL, de Oliveira Junior ER, Souza LG, Batista AC, Lima EM. Thermoreversible mucoadhesive polymer\u2013drug dispersion for sustained local delivery of budesonide to treat inflammatory disorders of the GI tract. J Control Release. 2019;303:12\u201323. https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.011.","journal-title":"J Control Release"},{"key":"3348_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111643","volume":"119","author":"JB da Silva","year":"2021","unstructured":"da Silva JB, dos Santos RS, da Silva MB, Braga G, Cook MT, Bruschi ML. Interaction between mucoadhesive cellulose derivatives and Pluronic F127: investigation on the micelle structure and mucoadhesive performance. Mater Sci Eng C Mater Biol Appl. 2021;119:111643. https:\/\/doi.org\/10.1016\/j.msec.2020.111643.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1\u20132","key":"3348_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpharm.2014.04.040","volume":"468","author":"M Xu","year":"2014","unstructured":"Xu M, Sun M, Qiao H, Ping Q, Elamin ES. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid. Int J Pharm. 2014;468(1\u20132):165\u201371. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.04.040.","journal-title":"Int J Pharm"},{"key":"3348_CR63","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijbiomac.2013.07.017","volume":"61","author":"L Pachuau","year":"2013","unstructured":"Pachuau L, Mazumder B. Evaluation of Albizia procera gum as compression coating material for colonic delivery of budesonide. Int J Biol Macromol. 2013;61:333\u20139. https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.07.017.","journal-title":"Int J Biol Macromol"},{"key":"3348_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.colsurfb.2015.11.048","volume":"138","author":"ACS Akkari","year":"2016","unstructured":"Akkari ACS, Campos EVR, Keppler AF, Fraceto LF, de Paula E, T\u00f3foli GR, et al. Budesonide\u2013hydroxypropyl-\u03b2-cyclodextrin inclusion complex in binary poloxamer 407\/403 system for ulcerative colitis treatment: a physico-chemical study from micelles to hydrogels. Colloids Surf B Biointerfaces. 2016;138:138\u201347. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.11.048.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"3348_CR65","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ejpb.2007.06.007","volume":"68","author":"MS Crcarevska","year":"2008","unstructured":"Crcarevska MS, Dodov MG, Goracinova K. Chitosan-coated Ca\u2013alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm. 2008;68(3):565\u201378. https:\/\/doi.org\/10.1016\/j.ejpb.2007.06.007.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR66","doi-asserted-by":"publisher","unstructured":"Rajabi-Siahboomi AR, Mehta RY, Ambudkar V, Dias V, Tiwari S. Ethylcellulose applications in multiparticulate systems. In: Rajabi-Siahboomi AR, editor. Multiparticulate Drug Delivery. New York (NY): Springer; 2017:267\u201399. https:\/\/doi.org\/10.1007\/978-1-4939-7012-4_11.","DOI":"10.1007\/978-1-4939-7012-4_11"},{"key":"3348_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106122","volume":"171","author":"Y Turanl\u0131","year":"2022","unstructured":"Turanl\u0131 Y, Acart\u00fcrk F. Preparation and characterization of colon-targeted pH\/time-dependent nanoparticles using anionic and cationic polymethacrylate polymers. Eur J Pharm Sci. 2022;171:106122. https:\/\/doi.org\/10.1016\/j.ejps.2022.106122.","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"3348_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103606","volume":"28","author":"H Azehaf","year":"2023","unstructured":"Azehaf H, Benzine Y, Tagzirt M, Skiba M, Karrout Y. Microbiota-sensitive drug delivery systems based on natural polysaccharides for colon targeting. Drug Discov Today. 2023;28(7):103606. https:\/\/doi.org\/10.1016\/j.drudis.2023.103606.","journal-title":"Drug Discov Today"},{"key":"3348_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/DDDT.S123412","volume":"11","author":"MS Kim","year":"2017","unstructured":"Kim MS, Yeom DW, Kim SR, Yoon HY, Kim CH, Son HY, et al. Development of a chitosan-based double layer-coated tablet as a platform for colon-specific drug delivery. Drug Des Devel Ther. 2017;11:45\u201357. https:\/\/doi.org\/10.2147\/DDDT.S123412.","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"3348_CR70","first-page":"16","volume":"12","author":"GK Saraogi","year":"2023","unstructured":"Saraogi GK, Bagri R, Singh S, Parasha AK. Formulation development and characterization of surface-modified pectin microspheres for colon targeting. Bull Environ Pharmacol Life Sci. 2023;12(9):16\u201323.","journal-title":"Bull Environ Pharmacol Life Sci"},{"key":"3348_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2022.100156","volume":"5","author":"S Narala","year":"2023","unstructured":"Narala S, Nyavanandi D, Mandati P, Youssef AAA, Alzahrani A, Kolimi P, et al. Preparation and in vitro evaluation of hot-melt extruded pectin-based pellets containing ketoprofen for colon targeting. International Journal of Pharmaceutics: X. 2023;5:100156. https:\/\/doi.org\/10.1016\/j.ijpx.2022.100156.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"4","key":"3348_CR72","first-page":"98","volume":"9","author":"SS Mishra","year":"2020","unstructured":"Mishra SS, Nayak RK, Das SN. Formulation and evaluation of colon-targeted drug delivery system of budesonide using xylan as a carrier. J Drug Deliv Ther. 2020;9(4):98\u2013107.","journal-title":"J Drug Deliv Ther"},{"issue":"4","key":"3348_CR73","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/10717541003667806","volume":"17","author":"DA Quinteros","year":"2010","unstructured":"Quinteros DA, Manzo RH, Allemandi DA. Design of a colonic delivery system based on cationic polymethacrylate (Eudragit E100)\u2013mesalamine complexes. Drug Deliv. 2010;17(4):208\u201313. https:\/\/doi.org\/10.3109\/10717541003667806.","journal-title":"Drug Deliv"},{"key":"3348_CR74","doi-asserted-by":"publisher","unstructured":"Bansal K, Jindal AB. An insight into risk assessment and reformulation of drug products manufactured using benzene grade carbomer: a regulatory perspective. AAPS PharmSciTech. 2024;25:166. https:\/\/doi.org\/10.1208\/s12249-024-02885-9.","DOI":"10.1208\/s12249-024-02885-9"},{"issue":"4","key":"3348_CR75","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.addr.2003.10.017","volume":"56","author":"T Minko","year":"2004","unstructured":"Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliv Rev. 2004;56(4):491\u2013509. https:\/\/doi.org\/10.1016\/j.addr.2003.10.017.","journal-title":"Adv Drug Deliv Rev"},{"key":"3348_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115479","volume":"216","author":"H Zhu","year":"2025","unstructured":"Zhu H, Kuang H, Huang X, Li X, Zhao R, Shang G, et al. 3D printing of drug delivery systems enhanced with micro\/nano-technology. Adv Drug Deliv Rev. 2025;216:115479. https:\/\/doi.org\/10.1016\/j.addr.2024.115479.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"3348_CR77","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1081\/DDC120021315","volume":"29","author":"M Qi","year":"2003","unstructured":"Qi M, Wang P, Wu D. A novel ph- and time-dependent system for colonic drug delivery. Drug Dev Ind Pharm. 2003;29(6):661\u20137. https:\/\/doi.org\/10.1081\/DDC120021315.","journal-title":"Drug Dev Ind Pharm"},{"key":"3348_CR78","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10787-023-01140-0","volume":"31","author":"HS Sardou","year":"2023","unstructured":"Sardou HS, Vosough PR, Abbaspour M, Akhgari A, Sathyapalan T, Sahebkar A. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease. Inflammopharmacol. 2023;31:1095\u2013105. https:\/\/doi.org\/10.1007\/s10787-023-01140-0.","journal-title":"Inflammopharmacol"},{"key":"3348_CR79","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s13346-020-00756-x","volume":"10","author":"N Desai","year":"2020","unstructured":"Desai N, Momin M. Colon-targeted bioadhesive pellets of curcumin and cyclosporine for improved management of inflammatory bowel disease. Drug Deliv Transl Res. 2020;10:1288\u2013301. https:\/\/doi.org\/10.1007\/s13346-020-00756-x.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3348_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/17425247.2013.736962","volume":"10","author":"S Thakral","year":"2012","unstructured":"Thakral S, Thakral NK, Majumdar DK. Eudragit\u00ae: a technology evaluation. Expert Opin Drug Deliv. 2012;10(1):131\u201349. https:\/\/doi.org\/10.1517\/17425247.2013.736962.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3348_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/polym12010234","volume":"12","author":"P Franco","year":"2020","unstructured":"Franco P, De Marco I. Eudragit: a novel carrier for controlled drug delivery in supercritical antisolvent coprecipitation. Polymers. 2020;12(1):234. https:\/\/doi.org\/10.3390\/polym12010234.","journal-title":"Polymers"},{"key":"3348_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106072","volume":"168","author":"HS Sardou","year":"2022","unstructured":"Sardou HS, Akhgari A, Mohammadpour AH, Namdar AB, Kamali H, Jafarian AH, et al. Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon-targeted delivery of 5-ASA pellets in rats with ulcerative colitis. Eur J Pharm Sci. 2022;168:106072. https:\/\/doi.org\/10.1016\/j.ejps.2021.106072.","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"3348_CR83","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-5173(00)00649-9","volume":"213","author":"VK Gupta","year":"2001","unstructured":"Gupta VK, Beckert TE, Price JC. A novel ph- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm. 2001;213(1\u20132):83\u201391. https:\/\/doi.org\/10.1016\/S0378-5173(00)00649-9.","journal-title":"Int J Pharm"},{"key":"3348_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100156","volume":"11","author":"RS Shendge","year":"2024","unstructured":"Shendge RS, Zalte TS, Khade SB. Polymeric microspheres redefining the landscape of colon-targeted delivery: a contemporary update. Eur J Med Chem Rep. 2024;11:100156. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100156.","journal-title":"Eur J Med Chem Rep"},{"key":"3348_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104927","volume":"88","author":"F Soltani","year":"2023","unstructured":"Soltani F, Kamali H, Akhgari A, Rahbardar MG, Garekani HA, Nokhodchi A, et al. Combination of time-dependent polymer and inulin as a coating for sustained delivery of budesonide pellets aimed for use in IBD treatment. J Drug Deliv Sci Technol. 2023;88:104927. https:\/\/doi.org\/10.1016\/j.jddst.2023.104927.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR86","unstructured":"eMC. Budenofalk 3 mg gastro-resistant capsules. 2020.https:\/\/www.medicines.org.uk\/emc\/product\/138\/pil. Accessed 19 March 2025."},{"key":"3348_CR87","unstructured":"eMC.Budesonide CR 3 mg capsules. 2023. https:\/\/www.medicines.org.uk\/emc\/files\/pil.14947.pdf. Accessed 19 March 2025."},{"key":"3348_CR88","unstructured":"Ferring. Cortiment MMX\u00ae: a new treatment for ulcerative colitis receives European approval. 2024.https:\/\/www.ferring.com\/cortimentmmx-a-new-treatment-for-ulcerative-colitis-receives-european-approval\/. Accessed 30 March 2024."},{"key":"3348_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121121","volume":"608","author":"RS Herbada","year":"2021","unstructured":"Herbada RS, Torres-Su\u00e1rez AI, Otero-Espinar FJ, Fraguas-Sanchez AI, Lopez-Cabarcos E, Rubio-Retama J, et al. Matrix tablets based on a novel poly(magnesium acrylate) hydrogel for the treatment of inflammatory bowel diseases. Int J Pharm. 2021;608:121121. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121121.","journal-title":"Int J Pharm"},{"key":"3348_CR90","unstructured":"DailyMed. Label: UCERIS \u2013 budesonide tablet, extended release. 2024.https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=92cbb190-8851-46ed-bfe0-166ca62ef2e9&type=display. Accessed 05 July 2025."},{"key":"3348_CR91","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/TCRM.S263835","volume":"17","author":"G Maconi","year":"2021","unstructured":"Maconi G, Camatta D, Cannatelli R, Ferretti F, Carvalhas Gabrielli A, Ardizzone S. Budesonide MMX in the treatment of ulcerative colitis: current perspectives on efficacy and safety. Ther Clin Risk Manag. 2021;17:285\u201392. https:\/\/doi.org\/10.2147\/TCRM.S263835.","journal-title":"Ther Clin Risk Manag"},{"key":"3348_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105617","volume":"157","author":"A Effinger","year":"2021","unstructured":"Effinger A, O\u2019Driscoll CM, McAllister M, Fotaki N. Predicting budesonide performance in healthy subjects and patients with Crohn\u2019s disease using biorelevant in vitro dissolution testing and PBPK modeling. Eur J Pharm Sci. 2021;157:105617. https:\/\/doi.org\/10.1016\/j.ejps.2020.105617.","journal-title":"Eur J Pharm Sci"},{"key":"3348_CR93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jddst.2014.12.002","volume":"25","author":"A Goyanes","year":"2015","unstructured":"Goyanes A, Hatton GB, Basit AW. A dynamic in\u00a0vitro model to evaluate the intestinal release behaviour of modified-release corticosteroid products. J Drug Deliv Sci Technol. 2015;25:36\u201342. https:\/\/doi.org\/10.1016\/j.jddst.2014.12.002.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biomaterials.2018.09.005","volume":"185","author":"AA Date","year":"2018","unstructured":"Date AA, Halpert G, Babu T, Ortiz J, Kanvinde P, Dimitrion P, et al. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials. 2018;185:97\u2013105. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.09.005.","journal-title":"Biomaterials"},{"issue":"2","key":"3348_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020161","volume":"13","author":"G Lemmens","year":"2021","unstructured":"Lemmens G, Van Camp A, Kourula S, Vanuytsel T, Augustijns P. Drug disposition in the lower gastrointestinal tract: targeting and monitoring. Pharmaceutics. 2021;13(2):161. https:\/\/doi.org\/10.3390\/pharmaceutics13020161.","journal-title":"Pharmaceutics"},{"key":"3348_CR96","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10620-015-3897-0","volume":"61","author":"GR Lichtenstein","year":"2016","unstructured":"Lichtenstein GR. Budesonide multi-matrix for the treatment of patients with ulcerative colitis. Dig Dis Sci. 2016;61:358\u201370. https:\/\/doi.org\/10.1007\/s10620-015-3897-0.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3348_CR97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5681\/apb.2013.014","volume":"3","author":"A Akhgari","year":"2013","unstructured":"Akhgari A, Heshmati Z, Sharif Makhmalzadeh B. Indomethacin electrospun nanofibers for colonic drug delivery: preparation and characterization. Adv Pharm Bull. 2013;3(1):85\u201390. https:\/\/doi.org\/10.5681\/apb.2013.014.","journal-title":"Adv Pharm Bull"},{"key":"3348_CR98","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jddst.2019.04.006","volume":"52","author":"E Kaffash","year":"2019","unstructured":"Kaffash E, Saremnejad F, Abbaspour M, Mohajeri SA, Garekani HA, Jafarian AH, et al. Statistical optimization of alginate-based oral dosage form of 5-aminosalicylic acid aimed to colonic delivery: in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2019;52:177\u201388. https:\/\/doi.org\/10.1016\/j.jddst.2019.04.006.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101495","volume":"55","author":"R Deshmukh","year":"2020","unstructured":"Deshmukh R, Harwansh RK, Das Paul S, Shukla R. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. J Drug Deliv Sci Technol. 2020;55:101495. https:\/\/doi.org\/10.1016\/j.jddst.2019.101495.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119379","volume":"583","author":"F Varum","year":"2020","unstructured":"Varum F, Freire AC, Fadda HM, Bravo R, Basit AW. A dual pH and microbiota-triggered coating (Phloral\u2122) for fail-safe colonic drug release. Int J Pharm. 2020;583:119379. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119379.","journal-title":"Int J Pharm"},{"key":"3348_CR101","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1007\/s12247-023-09764-z","volume":"18","author":"J Patel","year":"2023","unstructured":"Patel J, Patel K, Shah S. Fabrication of a dual-triggered natural gum\u2013based multi-particulate colon-targeted drug delivery system of budesonide using the qbd approach. J Pharm Innov. 2023;18:1992\u20132012. https:\/\/doi.org\/10.1007\/s12247-023-09764-z.","journal-title":"J Pharm Innov"},{"key":"3348_CR102","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/905191","volume":"2012","author":"J Varshosaz","year":"2012","unstructured":"Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F. Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide. J Drug Deliv. 2012;2012:905191. https:\/\/doi.org\/10.1155\/2012\/905191.","journal-title":"J Drug Deliv"},{"key":"3348_CR103","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.matpr.2022.09.464","volume":"70","author":"J Mancilla-De-la-Cruz","year":"2022","unstructured":"Mancilla-De-la-Cruz J, Rodriguez-Salvador M. Applications of 3D printing technologies in oral drug delivery. Materials Today: Proceedings. 2022;70:477\u201382. https:\/\/doi.org\/10.1016\/j.matpr.2022.09.464.","journal-title":"Materials Today: Proceedings"},{"key":"3348_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123366","volume":"645","author":"M Asadi","year":"2023","unstructured":"Asadi M, Salehi Z, Akrami M, Hosseinpour M, Jockenh\u00f6vel S, Ghazanfari S. 3D printed pH-responsive tablets containing N-acetylglucosamine-loaded methylcellulose hydrogel for colon drug delivery applications. Int J Pharm. 2023;645:123366.","journal-title":"Int J Pharm"},{"key":"3348_CR105","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02965-w","volume":"25","author":"ND Alshammari","year":"2024","unstructured":"Alshammari ND, Elkanayati R, Vemula SK, Al Shawakri E, Uttreja P, Almutairi M, et al. Advancements in colon-targeted drug delivery: a comprehensive review on recent techniques with emphasis on hot-melt extrusion and 3D printing technologies. AAPS PharmSciTech. 2024;25:236. https:\/\/doi.org\/10.1208\/s12249-024-02965-w.","journal-title":"AAPS PharmSciTech"},{"key":"3348_CR106","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jconrel.2024.04.016","volume":"369","author":"LE McCoubrey","year":"2024","unstructured":"McCoubrey LE, Seegobin N, Sangfuang N, Moens F, Duyvejonck H, Declerck E, et al. The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome. J Control Release. 2024;369:630\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.016.","journal-title":"J Control Release"},{"key":"3348_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213735","volume":"157","author":"ME Rabeh","year":"2024","unstructured":"Rabeh ME, Vora LK, Moore JV, Bayan MF, McCoy CP, Wylie MP. Dual stimuli-responsive delivery system for self-regulated colon-targeted delivery of poorly water-soluble drugs. Biomater. 2024;157:213735. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213735.","journal-title":"Biomater"},{"key":"3348_CR108","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jconrel.2019.10.054","volume":"316","author":"S Li","year":"2019","unstructured":"Li S, Xie A, Li H, Zou X, Zhang Q. A self-assembled, ROS-responsive janus-prodrug for targeted therapy of inflammatory bowel disease. J Control Release. 2019;316:66\u201378. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.054.","journal-title":"J Control Release"},{"issue":"9","key":"3348_CR109","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1517\/17425247.2015.1060217","volume":"12","author":"MM Patel","year":"2015","unstructured":"Patel MM. Colon: a gateway for chronotherapeutic drug delivery systems. Expert Opin Drug Deliv. 2015;12(9):1389\u201395. https:\/\/doi.org\/10.1517\/17425247.2015.1060217.","journal-title":"Expert Opin Drug Deliv"},{"key":"3348_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2025.103503","volume":"341","author":"S Liang","year":"2025","unstructured":"Liang S, Zhao D, Liu X, Liu B, Li Y. The stomach, small intestine, and colon-specific gastrointestinal tract delivery systems for bioactive nutrients. Adv Colloid Interface Sci. 2025;341:103503. https:\/\/doi.org\/10.1016\/j.cis.2025.103503.","journal-title":"Adv Colloid Interface Sci"},{"issue":"1\u20132","key":"3348_CR111","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0168-3659(97)00201-0","volume":"52","author":"M Muraoka","year":"1998","unstructured":"Muraoka M, Hu Z, Shimokawa T, Sekino S, Kurogoshi R, Kuboi Y, et al. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J Control Release. 1998;52(1\u20132):119\u201329. https:\/\/doi.org\/10.1016\/S0168-3659(97)00201-0.","journal-title":"J Control Release"},{"issue":"2","key":"3348_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2023.113403","volume":"173","author":"S Zhao","year":"2023","unstructured":"Zhao S, Zhao Y, Yang X, Zhao T. Recent research advances on oral colon-specific delivery system of nature bioactive components: a review. Food Res Int. 2023;173(2):113403. https:\/\/doi.org\/10.1016\/j.foodres.2023.113403.","journal-title":"Food Res Int"},{"issue":"1","key":"3348_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejpb.2010.01.006","volume":"75","author":"I Terebesi","year":"2010","unstructured":"Terebesi I, Bodmeier R. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets. Eur J Pharm Biopharm. 2010;75(1):63\u201370. https:\/\/doi.org\/10.1016\/j.ejpb.2010.01.006.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR114","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-025-06868-5","volume":"36","author":"E Mart\u00ednez","year":"2025","unstructured":"Mart\u00ednez E, Gamboa J, Finkielstein CV, et al. Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications. J Mater Sci Mater Med. 2025;36:24. https:\/\/doi.org\/10.1007\/s10856-025-06868-5.","journal-title":"J Mater Sci Mater Med"},{"key":"3348_CR115","unstructured":"Drugs@FDA. FDA-approved drugs. 2025. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm. Accessed 17 May 2025."},{"key":"3348_CR116","unstructured":"Orange Book. Approved Drug Products with Therapeutic Equivalence Evaluations. 2025.https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ob\/index.cfm. Accessed 06 Nov 2025."},{"key":"3348_CR117","unstructured":"DailyMed. National Library of Medicine. 2025. https:\/\/dailymed.nlm.nih.gov\/dailymed\/. Accessed 06 Nov 2025."},{"key":"3348_CR118","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jconrel.2017.07.043","volume":"262","author":"T Chen","year":"2017","unstructured":"Chen T, Li J, Chen T, Sun CC, Zheng Y. Tablets of multi-unit pellet system for controlled drug delivery. J Control Release. 2017;262:222\u201331. https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.043.","journal-title":"J Control Release"},{"key":"3348_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100299","volume":"8","author":"LR Oldfield","year":"2024","unstructured":"Oldfield LR, Mentrup AFC, Klinken-Uth S, Auel T, Seidlitz A. From design to 3D printing: a proof-of-concept study for multiple unit particle systems (MUPS) printed by dual extrusion fused filament fabrication. International Journal of Pharmaceutics: X. 2024;8:100299. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100299.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3348_CR120","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jconrel.2020.09.026","volume":"327","author":"R Ar\u00e9valo-P\u00e9rez","year":"2020","unstructured":"Ar\u00e9valo-P\u00e9rez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. J Control Release. 2020;327:703\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.026.","journal-title":"J Control Release"},{"key":"3348_CR121","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.powtec.2014.10.023","volume":"270","author":"T Peng","year":"2015","unstructured":"Peng T, Zhu C, Huang Y, Quan G, Huang L, Wu L, et al. Improvement of the stability of doxycycline hydrochloride pellet-containing tablets through a novel granulation technique and proper excipients. Powder Technol. 2015;270:221\u20139. https:\/\/doi.org\/10.1016\/j.powtec.2014.10.023.","journal-title":"Powder Technol"},{"key":"3348_CR122","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejps.2017.03.006","volume":"102","author":"HJ Park","year":"2017","unstructured":"Park HJ, Jung HJ, Ho MJ, Lee DR, Cho HR, Choi YS, et al. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet. Eur J Pharm Sci. 2017;102:172\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2017.03.006.","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"3348_CR123","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","volume":"14","author":"B Xie","year":"2024","unstructured":"Xie B, Liu Y, Li X, Yang P, He W. Solubilization techniques used for poorly water-soluble drugs. Acta Pharm Sin B. 2024;14(11):4683\u2013716. https:\/\/doi.org\/10.1016\/j.apsb.2024.08.027.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"3348_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.apt.2022.103684","volume":"33","author":"F Soltani","year":"2022","unstructured":"Soltani F, Kamali H, Akhgari A, Afrasiabi Garekani H, Nokhodchi A, Sadeghi F. Different trends for preparation of budesonide pellets with enhanced dissolution rate. Adv Powder Technol. 2022;33(8):103684. https:\/\/doi.org\/10.1016\/j.apt.2022.103684.","journal-title":"Adv Powder Technol"},{"issue":"2","key":"3348_CR125","first-page":"32","volume":"8","author":"PRT Rao","year":"2011","unstructured":"Rao PRT, Bansal K, Padhee K, Sathapathy A, Kochhar PS. Dissolution enhancement of levonorgestrel by micronization: comparison with commercial product. Int J Pharm Sci Rev Res. 2011;8(2):32\u20134.","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"3","key":"3348_CR126","first-page":"315","volume":"1","author":"K Bansal","year":"2011","unstructured":"Bansal K, Pant P, Therdana Rao PR, Padhee K, Sathapathy A, Kochhar PS. Micronization and dissolution enhancement of norethindrone. Int J Res Pharm Chem. 2011;1(3):315\u20139.","journal-title":"Int J Res Pharm Chem"},{"issue":"2","key":"3348_CR127","first-page":"329","volume":"3","author":"P Pant","year":"2011","unstructured":"Pant P, Bansal K, Rao PRT, Padhee K, Sathapathy A, Kochhar PS. Micronization: an efficient tool for dissolution enhancement of dienogest. Int J Drug Dev Res. 2011;3(2):329\u201333.","journal-title":"Int J Drug Dev Res"},{"issue":"4","key":"3348_CR128","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/2045-080X.106239","volume":"3","author":"K Bansal","year":"2012","unstructured":"Bansal K, Pant P, Padhee K, Kochhar PS. Dissolution enhancement of Tibolone by micronization technique. Arch Pharm Pract. 2012;3(4):261\u20134.","journal-title":"Arch Pharm Pract"},{"key":"3348_CR129","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","volume":"16","author":"S Amidon","year":"2015","unstructured":"Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16:731\u201341. https:\/\/doi.org\/10.1208\/s12249-015-0350-9.","journal-title":"AAPS PharmSciTech"},{"key":"3348_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101273","volume":"54","author":"F Ronchi","year":"2019","unstructured":"Ronchi F, Sereno A, Paide M, Hennia I, Sacr\u00e9 P, Guillaume G, et al. Development and evaluation of budesonide-based modified-release liquid oral dosage forms. J Drug Deliv Sci Technol. 2019;54:101273. https:\/\/doi.org\/10.1016\/j.jddst.2019.101273.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR131","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/262194","volume":"2014","author":"H Bhatt","year":"2014","unstructured":"Bhatt H, Naik B, Dharamsi A. Solubility enhancement of budesonide and statistical optimization of coating variables for targeted drug delivery. J Pharm. 2014;2014:262194. https:\/\/doi.org\/10.1155\/2014\/262194.","journal-title":"J Pharm"},{"key":"3348_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120422","volume":"302","author":"V D'Amico","year":"2023","unstructured":"D\u2019Amico V, Arduino I, Vacca M, Iacobazzi RM, Altamura D, Lopalco A, et al. Colonic budesonide delivery by multistimuli alginate\/Eudragit\u00ae FS 30D\/inulin-based microspheres as a paediatric formulation. Carbohydr Polym. 2023;302:120422. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120422.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"3348_CR133","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpb.2012.07.014","volume":"82","author":"XQ Wang","year":"2012","unstructured":"Wang XQ, Zhang Q. Ph-sensitive polymeric nanoparticles to improve oral bioavailability of peptide\/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm. 2012;82(2):219\u201329. https:\/\/doi.org\/10.1016\/j.ejpb.2012.07.014.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR134","doi-asserted-by":"publisher","unstructured":"Roy A, Raza MA, Ghosh V, Ajazuddin. Diagnostic innovations and therapeutic potential of nanoparticulate delivery for colon cancer. Nano-Struct Nano-Objects. 2025;41:101426. https:\/\/doi.org\/10.1016\/j.nanoso.2024.101426.","DOI":"10.1016\/j.nanoso.2024.101426"},{"key":"3348_CR135","doi-asserted-by":"publisher","unstructured":"DCruz CEM, Kumar L, Shirodkar RK. Applications of nanocarriers in colon targeting. In: Kumar L, Pathak YV, editors. Nanocarriers Based Colon Targeting. Academic Press; 2025. pp. 83\u2013113. https:\/\/doi.org\/10.1016\/B978-0-443-24806-1.00004-2.","DOI":"10.1016\/B978-0-443-24806-1.00004-2"},{"key":"3348_CR136","doi-asserted-by":"publisher","unstructured":"Ita K. Drug delivery to the colon. In: Drug Delivery. Academic Press; 2025. p. 129\u201347. https:\/\/doi.org\/10.1016\/B978-0-443-26787-1.00007-2.","DOI":"10.1016\/B978-0-443-26787-1.00007-2"},{"key":"3348_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.618411","volume":"12","author":"MS Alqahtani","year":"2021","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021;12:618411. https:\/\/doi.org\/10.3389\/fphar.2021.618411.","journal-title":"Front Pharmacol"},{"key":"3348_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104646","volume":"208","author":"S Noreen","year":"2025","unstructured":"Noreen S, Maqbool I, Saleem A, Mahmood H, Rai N. Recent insights and applications of nanocarriers-based drug delivery systems for colonic drug delivery and cancer therapy: an updated review. Crit Rev Oncol Hematol. 2025;208:104646. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104646.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3348_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102452","volume":"63","author":"S Tambe","year":"2021","unstructured":"Tambe S, Jain D, Agarwal Y, Amin P. Hot-melt extrusion: highlighting recent advances in pharmaceutical applications. J Drug Deliv Sci Technol. 2021;63:102452. https:\/\/doi.org\/10.1016\/j.jddst.2021.102452.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100202","volume":"12","author":"H Ahmadi","year":"2024","unstructured":"Ahmadi H, Heydari M, Abdouss M, Jamalpoor Z, Fathi-karkan S, Rahdar A, et al. Metronidazole delivery strategies: optimizing cancer therapy through novel approaches for enhanced delivery, cytotoxicity, and side effect reduction. Eur J Med Chem Rep. 2024;12:100202. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100202.","journal-title":"Eur J Med Chem Rep"},{"key":"3348_CR141","doi-asserted-by":"publisher","unstructured":"Pandita D, Vakar P, Poonia N, Chaudhary G, Jain GK, Lather V, Khar RK. pH-sensitive polymeric nanocarriers for enhanced intracellular drug delivery. In: Vyas SP, Agrawal U, Sharma R, editors. Smart Polymeric Nano-Constructs in Drug Delivery. Academic Press; 2023. pp. 65\u2013107. https:\/\/doi.org\/10.1016\/B978-0-323-91248-8.00004-0.","DOI":"10.1016\/B978-0-323-91248-8.00004-0"},{"issue":"2","key":"3348_CR142","doi-asserted-by":"publisher","first-page":"286","DOI":"10.34172\/apb.2021.041","volume":"11","author":"A Salunke","year":"2021","unstructured":"Salunke A, Upmanyu N. Formulation, development and evaluation of budesonide oral nano-sponges using DOE approach: in vivo evidences. Adv Pharm Bull. 2021;11(2):286\u201394. https:\/\/doi.org\/10.34172\/apb.2021.041.","journal-title":"Adv Pharm Bull"},{"key":"3348_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118866","volume":"574","author":"NM Elbaz","year":"2020","unstructured":"Elbaz NM, Owen A, Rannard S, McDonald TO. Controlled synthesis of calcium carbonate nanoparticles and stimuli-responsive multi-layered nanocapsules for oral drug delivery. Int J Pharm. 2020;574:118866. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118866.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"3348_CR144","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2015.02.044","volume":"484","author":"V Petrovska-Jovanovska","year":"2015","unstructured":"Petrovska-Jovanovska V, Geskovski N, Simonoska Crcarevska M, Memed O, Petru\u0161evski G, Chachorovska M, et al. Formulation and characterization of ORMOSIL particles loaded with budesonide for local colonic delivery. Int J Pharm. 2015;484(1\u20132):75\u201384. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.02.044.","journal-title":"Int J Pharm"},{"key":"3348_CR145","doi-asserted-by":"publisher","unstructured":"Raval M, Sheth N, Ramani R. Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery. Int J Pharm Investig. 2013;3(4):203. https:\/\/doi.org\/10.4103\/2230-973X.121294.","DOI":"10.4103\/2230-973X.121294"},{"issue":"1\u20132","key":"3348_CR146","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijpharm.2010.05.003","volume":"395","author":"JF Pinto","year":"2010","unstructured":"Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395(1\u20132):44\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.05.003.","journal-title":"Int J Pharm"},{"issue":"Pt B","key":"3348_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106424","volume":"102","author":"S Wu","year":"2024","unstructured":"Wu S, Yang Y, Wang L, Jia C, Guan Z, Chen H, et al. Prediction of drug dissolution from sustained-release pellet by a portable near-infrared spectrometer. J Drug Deliv Sci Technol. 2024;102(Pt B):106424. https:\/\/doi.org\/10.1016\/j.jddst.2024.106424.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jddst.2014.12.003","volume":"25","author":"L Palugan","year":"2015","unstructured":"Palugan L, Cerea M, Zema L, Gazzaniga A, Maroni A. Coated pellets for oral colon delivery. J Drug Deliv Sci Technol. 2015;25:1\u201315. https:\/\/doi.org\/10.1016\/j.jddst.2014.12.003.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3348_CR149","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2008.08.005","volume":"71","author":"A Duki\u0107-Ott","year":"2009","unstructured":"Duki\u0107-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C. Production of pellets via extrusion\u2013spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm. 2009;71(1):38\u201346. https:\/\/doi.org\/10.1016\/j.ejpb.2008.08.005.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"3348_CR150","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijpharm.2007.02.015","volume":"338","author":"Y Krishnamachari","year":"2007","unstructured":"Krishnamachari Y, Madan P, Lin S. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm. 2007;338(1\u20132):238\u201347. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.02.015.","journal-title":"Int J Pharm"},{"issue":"5","key":"3348_CR151","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jsps.2015.01.020","volume":"24","author":"X Tan","year":"2016","unstructured":"Tan X, Hu J. Investigation for the quality factors on the tablets containing medicated pellets. Saudi Pharm J. 2016;24(5):507\u201314. https:\/\/doi.org\/10.1016\/j.jsps.2015.01.020.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"3348_CR152","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejpb.2008.11.005","volume":"72","author":"S Ensslin","year":"2009","unstructured":"Ensslin S, Moll KP, Metz H, Otz M, M\u00e4der K. Modulating ph-independent release from coated pellets: effect of coating composition on solubilization processes and drug release. Eur J Pharm Biopharm. 2009;72(1):111\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2008.11.005.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR153","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejpb.2020.03.020","volume":"151","author":"F Leonard","year":"2020","unstructured":"Leonard F, Srinivasan S, Liu X, Collnot EM, Ferrari M, Lehr CM, et al. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease. Eur J Pharm Biopharm. 2020;151:61\u201372. https:\/\/doi.org\/10.1016\/j.ejpb.2020.03.020.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103556","volume":"74","author":"A Gangopadhyay","year":"2022","unstructured":"Gangopadhyay A, Bose A, Rout SS, Mohapatra R. Application of dual modified corn starch as a polymer for the colon targeted direct compressible budesonide tablet. J Drug Deliv Sci Technol. 2022;74:103556. https:\/\/doi.org\/10.1016\/j.jddst.2022.103556.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"3348_CR155","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.nano.2018.01.003","volume":"14","author":"M Naeem","year":"2018","unstructured":"Naeem M, Oshi MA, Kim J, Lee J, Cao J, Nurhasni H, et al. Ph-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions. Nanomedicine. 2018;14(3):823\u201334. https:\/\/doi.org\/10.1016\/j.nano.2018.01.003.","journal-title":"Nanomedicine"},{"issue":"2","key":"3348_CR156","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","volume":"50","author":"MD Long","year":"2016","unstructured":"Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease. J Clin Gastroenterol. 2016;50(2):152\u20136. https:\/\/doi.org\/10.1097\/MCG.0000000000000421.","journal-title":"J Clin Gastroenterol"},{"key":"3348_CR157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40262-018-0676-z","volume":"58","author":"SE Berends","year":"2019","unstructured":"Berends SE, Strik AS, L\u00f6wenberg M, D\u2019Haens GR, Math\u00f4t RAA. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of ulcerative colitis. Clin Pharmacokinet. 2019;58:15\u201337. https:\/\/doi.org\/10.1007\/s40262-018-0676-z.","journal-title":"Clin Pharmacokinet"},{"key":"3348_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111582","volume":"119","author":"A Ahmad","year":"2021","unstructured":"Ahmad A, Ansari MM, Mishra RK, Kumar A, Vyawahare A, Verma RK, et al. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis. Materials Science and Engineering: C. 2021;119:111582. https:\/\/doi.org\/10.1016\/j.msec.2020.111582.","journal-title":"Materials Science and Engineering: C"},{"key":"3348_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/srep46693","volume":"7","author":"X Zhao","year":"2017","unstructured":"Zhao X, Zhou C, Ma J, et al. Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis. Sci Rep. 2017;7:46693. https:\/\/doi.org\/10.1038\/srep46693.","journal-title":"Sci Rep"},{"issue":"7","key":"3348_CR160","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ibd\/izy123","volume":"24","author":"M Zhang","year":"2018","unstructured":"Zhang M, Merlin D. Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis. Inflamm Bowel Dis. 2018;24(7):1401\u201315. https:\/\/doi.org\/10.1093\/ibd\/izy123.","journal-title":"Inflamm Bowel Dis"},{"key":"3348_CR161","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2016.07.010","volume":"116","author":"B Oc\u00f3n","year":"2016","unstructured":"Oc\u00f3n B, Aranda CJ, G\u00e1mez-Belmonte R, Su\u00e1rez MD, Zarzuelo A, Mart\u00ednez-Augustin O, et al. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem Pharmacol. 2016;116:73\u201388. https:\/\/doi.org\/10.1016\/j.bcp.2016.07.010.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"3348_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36259","volume":"10","author":"T Das","year":"2024","unstructured":"Das T, Rimti FH, Fahid HA, Uthso NA, Hawlader MDH. Prevalence of IBS and its association with academic stress and dormitory lifestyle among medical students of Bangladesh: a cross-sectional study. Heliyon. 2024;10(16):e36259. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36259.","journal-title":"Heliyon"},{"key":"3348_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2024.108187","volume":"160","author":"MJ Zvolensky","year":"2025","unstructured":"Zvolensky MJ, Smit T, Dragoi I, Tamminana R, Bakhshaie J, Ditre JW, et al. Irritable bowel syndrome (IBS) and smoking: an evaluation of IBS symptom severity and anxiety sensitivity among adults in the United States. Addict Behav. 2025;160:108187. https:\/\/doi.org\/10.1016\/j.addbeh.2024.108187.","journal-title":"Addict Behav"},{"issue":"1","key":"3348_CR164","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejpb.2011.01.004","volume":"78","author":"A Chaudhary","year":"2011","unstructured":"Chaudhary A, Tiwari N, Jain V, Singh R. Microporous bilayer osmotic tablet for colon-specific delivery. Eur J Pharm Biopharm. 2011;78(1):134\u201340. https:\/\/doi.org\/10.1016\/j.ejpb.2011.01.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"3348_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125402","volume":"673","author":"X Hu","year":"2025","unstructured":"Hu X, Liu J, Wang Q, Hu Q, Sun H, Wang S, et al. Colon cancer-cell-specific drug delivery by gemcitabine conjugated with peptide chain targeting ENO1. Int J Pharm. 2025;673:125402. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125402.","journal-title":"Int J Pharm"},{"key":"3348_CR166","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2017.12.013","volume":"271","author":"L Yin","year":"2018","unstructured":"Yin L, Meng Z, Zhang Y, Hu K, Chen W, Han K, et al. Bacillus spore-based oral carriers loading curcumin for the therapy of colon cancer. J Control Release. 2018;271:31\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.013.","journal-title":"J Control Release"},{"key":"3348_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155546","volume":"262","author":"R Kamal","year":"2024","unstructured":"Kamal R, Awasthi A, Paul P, Mir MS, Singh SK, Dua K. Novel drug delivery systems in colorectal cancer: advances and future prospects. Pathol Res Pract. 2024;262:155546. https:\/\/doi.org\/10.1016\/j.prp.2024.155546.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"3348_CR168","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.apsb.2024.09.015","volume":"14","author":"M Niu","year":"2024","unstructured":"Niu M, Pei Y, Jin T, Li J, Bai L, Zheng C, et al. Colon-specific controlled release of oral liposomes for enhanced chemo-immunotherapy against colorectal cancer. Acta Pharm Sin B. 2024;14(11):4977\u201393. https:\/\/doi.org\/10.1016\/j.apsb.2024.09.015.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"3348_CR169","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.dld.2020.06.008","volume":"52","author":"A Armuzzi","year":"2020","unstructured":"Armuzzi A, Bouhnik Y, Cummings F, Bettey M, Pieper B, Kang T. Enhancing treatment success in inflammatory bowel disease: optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice. Dig Liver Dis. 2020;52(11):1259\u201365.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"3348_CR170","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jfma.2018.07.005","volume":"118","author":"HJ Su","year":"2019","unstructured":"Su HJ, Chiu YT, Chiu CT, Lin YC, Wang CY, Hsieh JY, et al. Inflammatory bowel disease and its treatment in 2018: global and Taiwanese status updates. J Formos Med Assoc. 2019;118(7):1083\u201392. https:\/\/doi.org\/10.1016\/j.jfma.2018.07.005.","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"3348_CR171","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.gastre.2016.05.005","volume":"39","author":"M Chaparro","year":"2016","unstructured":"Chaparro M, Gisbert JP. New molecules in the treatment of inflammatory bowel disease. Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition). 2016;39(6):411\u201323. https:\/\/doi.org\/10.1016\/j.gastre.2016.05.005.","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition)"},{"key":"3348_CR172","doi-asserted-by":"publisher","unstructured":"Gupta M, Sen P, Saini M, Singh M, Bagiyal P, Kumar P, Gupta G. Current approaches for treatment of colonic disorder. In: Dureja H, Loebenberg R, Singh SK, Dhanasekaran M, Dua K, editors. Advanced Drug Delivery Systems for Colonic Disorders. Academic Press; 2024. pp. 43\u201365. https:\/\/doi.org\/10.1016\/B978-0-443-14044-0.00017-X.","DOI":"10.1016\/B978-0-443-14044-0.00017-X"},{"key":"3348_CR173","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41587-021-01024-0","volume":"40","author":"A Abramson","year":"2022","unstructured":"Abramson A, Frederiksen MR, Vegge A, Jensen B, Poulsen M, Mouridsen B, et al. Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors. Nat Biotechnol. 2022;40:103\u20139. https:\/\/doi.org\/10.1038\/s41587-021-01024-0.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"3348_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040397","volume":"17","author":"KC Baral","year":"2025","unstructured":"Baral KC, Choi KY. Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances. Pharmaceutics. 2025;17(4):397. https:\/\/doi.org\/10.3390\/pharmaceutics17040397.","journal-title":"Pharmaceutics"},{"key":"3348_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107205","volume":"112","author":"MA Al Tahan","year":"2025","unstructured":"Al Tahan MA, Al-Khattawi A, Russell C. Oral peptide delivery systems: synergistic approaches using polymers, lipids, nanotechnology, and needle-based carriers. J Drug Deliv Sci Technol. 2025;112:107205. https:\/\/doi.org\/10.1016\/j.jddst.2025.107205.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3348_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115603","volume":"222","author":"HP Gelli","year":"2025","unstructured":"Gelli HP, Vazquez-Uribe R, Buckley ST, Andersen JT, Sommer MOA. Advanced microbiome therapeutics for oral delivery of peptides and proteins: advances, challenges, and opportunities. Adv Drug Deliv Rev. 2025;222:115603. https:\/\/doi.org\/10.1016\/j.addr.2025.115603.","journal-title":"Adv Drug Deliv Rev"},{"key":"3348_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106523","volume":"190","author":"KT Kopp","year":"2023","unstructured":"Kopp KT, Saerens L, Voorspoels J, den Van Mooter G. Solidification and oral delivery of biologics to the colon: a review. Eur J Pharm Sci. 2023;190:106523. https:\/\/doi.org\/10.1016\/j.ejps.2023.106523.","journal-title":"Eur J Pharm Sci"},{"key":"3348_CR178","doi-asserted-by":"publisher","unstructured":"Tao J, Yang J, Zhao M, Zhu Q, Chen Z, Qi J. Emerging trends in permeation-enhancing technologies for oral peptide delivery. Chin Chem Lett. 2025;111170. https:\/\/doi.org\/10.1016\/j.cclet.2025.111170.","DOI":"10.1016\/j.cclet.2025.111170"},{"key":"3348_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116471","volume":"229","author":"Z Ke","year":"2024","unstructured":"Ke Z, Ma Q, Ye X, Wang Y, Jin Y, Zhao X, et al. Peptide GLP-1 receptor agonists: from injection to oral delivery strategies. Biochem Pharmacol. 2024;229:116471. https:\/\/doi.org\/10.1016\/j.bcp.2024.116471.","journal-title":"Biochem Pharmacol"},{"key":"3348_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120838","volume":"312","author":"H Yuan","year":"2023","unstructured":"Yuan H, Guo C, Liu L, Zhao L, Zhang Y, Yin T, et al. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins\/peptides. Carbohydr Polym. 2023;312:120838. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120838.","journal-title":"Carbohydr Polym"},{"issue":"5","key":"3348_CR181","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.apsb.2024.02.019","volume":"14","author":"B Ding","year":"2024","unstructured":"Ding B, Zhu Z, Guo C, Li J, Gan Y, Yu M. Oral peptide therapeutics for diabetes treatment: state-of-the-art and future perspectives. Acta Pharm Sin B. 2024;14(5):2006\u201325. https:\/\/doi.org\/10.1016\/j.apsb.2024.02.019.","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"3348_CR182","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.1021\/acsomega.8b01481","volume":"3","author":"N Kobayashi","year":"2018","unstructured":"Kobayashi N, Sato N, Fujimura Y, Kihara T, Sugita K, Takahashi K, et al. Discovery of the orally effective thyrotropin-releasing hormone mimetic: 1-{N-[(4S,5S)-(5-methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-L-alanyl}-(2R)-2-methylpyrrolidine trihydrate (rovatirelin hydrate). ACS Omega. 2018;3(10):13647\u201366. https:\/\/doi.org\/10.1021\/acsomega.8b01481.","journal-title":"ACS Omega"},{"key":"3348_CR183","unstructured":"USFDA. Clinical pharmacology and biopharmaceutics review(s). 2008. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/021795s000_ClinPharmR.pdf.\u00a0Accessed 09 Nov 2025."},{"key":"3348_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122643","volume":"634","author":"F Wang","year":"2023","unstructured":"Wang F, Sangfuang N, McCoubrey LE, Yadav V, Elbadawi M, Orlu M, et al. Advancing oral delivery of biologics: machine learning predicts peptide stability in the gastrointestinal tract. Int J Pharm. 2023;634:122643. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122643.","journal-title":"Int J Pharm"},{"key":"3348_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125888","volume":"681","author":"B \u00d6ngoren","year":"2025","unstructured":"\u00d6ngoren B, Kara A, Serrano DR, Lalatsa A. Novel enabling strategies for oral peptide delivery. Int J Pharm. 2025;681:125888. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125888.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03348-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03348-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:46:44Z","timestamp":1772228804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03348-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":185,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3348"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03348-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We used Grammarly and Microsoft co-pilot tools in order to refine language, improve grammar, modify sentences and arrange references. Authors take full responsibility and reviewed the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.The views expressed in this article are the author\u2019s personal opinion on the subject matter. Amneal Pharmaceuticals Ltd, India, cannot be held responsible for any representation made herewith. The brand names are presented here solely for educational purposes and must not be considered as our endorsement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"92"}}